Market Overview

Needham: Wright Medical Group A Buy After Latest Acquisition

Share:
Needham: Wright Medical Group A Buy After Latest Acquisition
Related WMGI
The Daily Biotech Pulse: SITC Presentations Pick Up Pace, Sandoz' Voluntary Recall
Benzinga's Top Upgrades, Downgrades For August 29, 2018
Wright Medical Group N.V. Announces Payment Date and Record Date for CVR Product Sales ... (GuruFocus)

Wright Medical Group NV (NASDAQ: WMGI)'s acquisition of Cartiva, a private orthopedic medical device company, resulted in a pullback in the stock that investors should take advantage of, according to Needham.

The Analyst

Needham's Mike Matson upgraded Wright Medical Group from Hold to Buy with a new $30 price target.

The Thesis

Wright Medical Group's acquisition of Cartiva is expensive based on the price tag, which implies a valuation of 9.3 times 2019 estimated EV/sales, Matson said in the upgrade note. (See the analyst's track record here.) 

At the same time, Cartiva's expected revenue growth of 50 percent in 2018 and 34 percent next year is above the group average, the analyst said. 

Cartiva gives Wright Medical Group immediate and direct exposure to the estimated $400-million osteoarthritis of the big toe market as it is the only approved cartilage-like polymer in the U.S., Matson said. While there will be some cannibalization of Wright Medical Group's products, it will come at Cartiva's much higher price point, as its products has an average selling price of $3,500 with a gross margin rate above 90 percent, he said. 

Wright Medical Group's guidance that Cartiva will contribute $47 million in revenue next year appears to be conservative, especially in the international market, which is a "mostly greenfield opportunity," the analyst said. 

Price Action

Wright Medical Group shares were rising 5.56 percent to $28.28 at the time of publication Tuesday. 

Related Links:

Wright Medical Is Headed For Double-Digit Growth, Stifel Says In Bullish Initiation

Jefferies Says Wright Medical A Top Pick, Management Meetings 'Heartening'

Latest Ratings for WMGI

DateFirmActionFromTo
Nov 2018UBSInitiates Coverage OnNeutral
Nov 2018BairdMaintainsOutperformOutperform
Nov 2018JefferiesMaintainsBuyBuy

View More Analyst Ratings for WMGI
View the Latest Analyst Ratings

Posted-In: medical device Mike MatsonAnalyst Color Upgrades Health Care Price Target Analyst Ratings General Best of Benzinga

 

Related Articles (WMGI)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
TVPTImperial CapitalDowngrades15.8
ACORGoldman SachsDowngrades10.0
APTIJefferiesDowngrades38.0
BCOVB. Riley FBRUpgrades12.0
CAMPFirst AnalysisDowngrades22.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

NPD Group: Vans A Winner In Weak Back-To-School Season

Mid-Afternoon Market Update: Affimed Jumps On Collaboration With Roche's Genentech; Mitek Systems Shares Drop